Bloomberg · Ike Swetlitz ·

Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation

Science Corp, the company behind a retinal chip that restores some vision to people with an age-related form of blindness, is valued at $3.5 billion after a recent fundraising round.

Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation

Lead Source

How this story grew

Coverage · 0 Discussion · 0
Nov 17Nov 18

More

TechCrunch: TechCrunch
TeslaNorth.com: TeslaNorth.com
iPhone in Canada: iPhone in Canada

Discussion

Related stories